Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Neumora Therapeutics Inc.
Sponsor

Neumora Therapeutics Inc.

United States 260 Arsenal Place Suite 1, 02472-3171, United States

About the sponsor

Neumora Therapeutics Inc. focuses its clinical research on major depressive disorder, with studies centered on symptom reduction and the ongoing management of depressive illness in adults.

  • Depression symptom control
  • Adult psychiatry
  • Mood disorder treatment

The sponsor’s trial portfolio is concentrated in psychiatric drug development for depression-related conditions.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on the Effects of NMRA-335140 for Adults with Major Depressive Disorder

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
  • Sponsor:Neumora Therapeutics Inc.

Study on Long-term Safety and Effectiveness of NMRA-335140 for Patients with Major Depressive Disorder

Not recruiting
InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine
  • Sponsor:Neumora Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.